Clinical trial
AMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's Disease
NCT00004576 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's Disease
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2000
- Completion date
- August 31, 2000
- Enrollment
- 20
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.